Aeluma reported fourth-quarter 2026 revenue of $0.6 million, aligning with expectations as the company transitions from government R&D to commercial-scale photonics. While GAAP losses per share of $0.22 were significantly wider than the estimated $0.07 due to aggressive hiring and manufacturing investments, liquidity strengthened to $56.0 million following a $20.1 million at-the-market capital raise.
Key Highlights
- Signed a non-binding Letter of Intent for up to $30 million in CHIPS Act funding to accelerate commercialization of photonics for AI and advanced computing.
- Executed six new contracts with a total value of $5.3 million, including awards from NASA and the U.S. Navy to advance laser and quantum technologies.
- Secured a strategic agreement with Sumitomo Chemical Advanced Technologies to increase wafer capacity and procurement of additional MOCVD tools for non-InP platforms.